Cyclo Therapeutics Inc (CYTH)
1.51
+0.04
(+2.72%)
USD |
NASDAQ |
May 03, 16:00
1.51
0.00 (0.00%)
After-Hours: 20:00
Cyclo Therapeutics Debt to Equity Ratio: 0.00 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.0097 |
| September 30, 2021 | 0.0199 |
| June 30, 2021 | 0.0142 |
| March 31, 2021 | 0.0111 |
| December 31, 2020 | 0.0152 |
| September 30, 2020 | -0.3022 |
| June 30, 2020 | -0.0826 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.2579 |
| June 30, 2016 | 0.179 |
| March 31, 2016 | 0.2331 |
| December 31, 2015 | 0.1969 |
| September 30, 2015 | 0.1562 |
| June 30, 2015 | 0.2103 |
| March 31, 2015 | 0.195 |
| December 31, 2014 | 0.1818 |
| September 30, 2014 | 0.1755 |
| June 30, 2014 | 0.262 |
| March 31, 2014 | 0.3645 |
| December 31, 2013 | 0.4745 |
| September 30, 2013 | 0.4811 |
| June 30, 2013 | 0.4697 |
| March 31, 2013 | 0.5681 |
| December 31, 2012 | 0.6367 |
| September 30, 2012 | 0.6149 |
| June 30, 2012 | 0.6256 |
| March 31, 2012 | 0.6097 |
| December 31, 2011 | 0.5874 |
| September 30, 2011 | 0.553 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-0.3022
Minimum
Sep 2020
0.0199
Maximum
Sep 2021
-0.0166
Average
--
Median
Jun 2019
Debt to Equity Ratio Benchmarks
| NovaBay Pharmaceuticals Inc | 0.3431 |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 13.25M |
| Total Liabilities (Quarterly) | 8.490M |
| Shareholders Equity (Quarterly) | 4.757M |
| Current Ratio | 1.455 |